Cargando…

Alum‐adjuvanted allergoids induce functional IgE‐blocking antibodies

Detalles Bibliográficos
Autores principales:	Reithofer, M., Böll, S. L., Kitzmüller, C., Horak, F., Sotoudeh, M., Bohle, B., Jahn‐Schmid, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001745/ https://www.ncbi.nlm.nih.gov/pubmed/29436051 http://dx.doi.org/10.1111/cea.13120

Ejemplares similares

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
por: Reithofer, Manuel, et al.
Publicado: (2023)

Alum triggers infiltration of human neutrophils ex vivo and causes lysosomal destabilization and mitochondrial membrane potential‐dependent NET‐formation
por: Reithofer, Manuel, et al.
Publicado: (2020)

Depigmented Allergoids Reveal New Epitopes with Capacity to Induce IgG Blocking Antibodies
por: López-Matas, M. Angeles, et al.
Publicado: (2013)

Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps
por: Karacs, Jasmine, et al.
Publicado: (2021)

98 Specific IGE and IGG Binding to Allergoids of Phleum pratense
por: Cases, Barbara, et al.
Publicado: (2012)

The Effect of IFN-γ, Alum and Complete Freund Adjuvant on TNP-KLH Induced Ig.G(1), IgE and IgG(2a) Responses in Mice
por: van Ommen, R., et al.
Publicado: (1994)

IgG1/IgE ratio is relevant for the protective effect of an alum-adjuvated allergen vaccine in a murine model of local allergen challenge
por: González, Wendy Ramírez, et al.
Publicado: (2015)

Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs
por: Benito‐Villalvilla, Cristina, et al.
Publicado: (2019)

Dramatically decreased T cell responses but persistent IgE upon reduced pollen exposure
por: Van Hemelen, Dries, et al.
Publicado: (2019)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018)

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
por: Nyborg, Andrew C, et al.
Publicado: (2016)

Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
por: Kitzmüller, Claudia, et al.
Publicado: (2019)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils
por: El Ansari, Yasmeen S., et al.
Publicado: (2022)

Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
por: Bracken, Sonali J., et al.
Publicado: (2018)

Mimicry of human IgE epitopes by anti-idiotypic antibodies
por: Vogel, Monique, et al.
Publicado: (2000)

Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions
por: Ando, Tomoaki, et al.
Publicado: (2021)

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

A Temporal Model of Human IgE and IgG Antibody Function
por: Collins, Andrew M., et al.
Publicado: (2013)

Highly Cytokinergic IgE Antibodies and Autoimmune Mechanisms
por: Kim, Mi-Ae, et al.
Publicado: (2012)

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

IgE Antibodies against Cancer: Efficacy and Safety
por: Chauhan, Jitesh, et al.
Publicado: (2020)

IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
por: Plattner, Kevin, et al.
Publicado: (2022)

Engineered immunogen binding to alum adjuvant enhances humoral immunity
por: Moyer, Tyson J., et al.
Publicado: (2020)

IgE Antibodies: From Structure to Function and Clinical Translation
por: Sutton, Brian J., et al.
Publicado: (2019)

“Auto-anti-IgE”: Naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation
por: Chan, Yih-Chih, et al.
Publicado: (2014)

In Planta Glycan Engineering and Functional Activities of IgE Antibodies
por: Montero-Morales, Laura, et al.
Publicado: (2019)

Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy
por: Starchenka, Sviatlana, et al.
Publicado: (2019)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016)

Self-reactive IgE and anti-IgE therapy in autoimmune diseases
por: Olewicz-Gawlik, Anna, et al.
Publicado: (2023)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti‐IgE/IgE immune complexes
por: Bundhoo, A., et al.
Publicado: (2015)

Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4(+) T cells from allergic patients
por: Deifl, S., et al.
Publicado: (2014)

Allergen skin test reactivity and asthma are inversely associated with ratios of IgG4/IgE and total IgE/allergen‐specific IgE in Ugandan communities
por: Nkurunungi, Gyaviira, et al.
Publicado: (2021)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
por: Kumagai, Akiko, et al.
Publicado: (2021)

Blocking of Histamine Release and IgE Binding to FcεRI on Human Basophils by Antibodies Produced in Camels
por: Khaled, Al-Qaoud, et al.
Publicado: (2015)

Fel d1 Blocking Antibodies: A Novel Method to Reduce IgE-Mediated Allergy to Cats
por: Satyaraj, Ebenezer, et al.
Publicado: (2021)

STUDIES ON ANTIBODY PRODUCTION : III. THE ALUM GRANULOMA
por: White, Robert G., et al.
Publicado: (1955)

Cannot write session to /tmp/vufind_sessions/sess_1ud3pcss5p4fpsho6563k2qrkl